Jules Mitchel, MBA, Ph.D.
Investigator
President and CEO, THI Pharma Services Inc.
New York, New York
Recent Publications
Mitchel, JT., Rojas, LA, Helfgott, JS. Analysis: FDA’s COVID-19 Accelerated Pathways. Appl Clin Trials 2021;30 (12)
Park, GD, Mitchel, JT. Working with the U.S. Food and Drug Administration to obtain approval of products under the Animal Rule. Ann N Y Acad Sci. 2016;1374 (1):10-6. PubMed PMID:27336401 .
Morrison, BW, Cochran, CJ, White, JG, Harley, J, Kleppinger, CF, Liu, A, Mitchel, JT, Nickerson, DF, Zacharias, CR, Kramer, JM, Neaton, JD. Monitoring the quality of conduct of clinical trials: a survey of current practices. Clin Trials. 2011;8 (3):342-9. PubMed PMID:21730082 .
Mitchel, JT, Kim, YJ, Choi, J, Park, G, Cappi, S, Horn, D, Kist, M, D Agostino, RB Jr. Evaluation of Data Entry Errors and Data Changes to an Electronic Data Capture Clinical Trial Database. Drug Inf J. 2011;45 (4):421-430. PubMed PMID:24058221 PubMed Central PMC3777611.
More Publications